160 related articles for article (PubMed ID: 38405101)
1. NUPR1 packaged in extracellular vesicles promotes murine triple-negative breast cancer in a type 1 interferon-independent manner.
Ortiz A; Stavrou A; Liu S; Chen D; Shen SS; Jin C
Extracell Vesicles Circ Nucl Acids; 2024; 5(1):19-36. PubMed ID: 38405101
[TBL] [Abstract][Full Text] [Related]
2. Chronic nickel exposure alters extracellular vesicles to mediate cancer progression via sustained NUPR1 expression.
Liu S; Costa M; Ortiz A
J Inorg Biochem; 2024 Mar; 252():112477. PubMed ID: 38199052
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles in cancer progression.
Ortiz A
Semin Cancer Biol; 2021 Nov; 76():139-142. PubMed ID: 34090999
[TBL] [Abstract][Full Text] [Related]
4. An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles.
Ortiz A; Gui J; Zahedi F; Yu P; Cho C; Bhattacharya S; Carbone CJ; Yu Q; Katlinski KV; Katlinskaya YV; Handa S; Haas V; Volk SW; Brice AK; Wals K; Matheson NJ; Antrobus R; Ludwig S; Whiteside TL; Sander C; Tarhini AA; Kirkwood JM; Lehner PJ; Guo W; Rui H; Minn AJ; Koumenis C; Diehl JA; Fuchs SY
Cancer Cell; 2019 Jan; 35(1):33-45.e6. PubMed ID: 30645975
[TBL] [Abstract][Full Text] [Related]
5. WTAP Mediates NUPR1 Regulation of LCN2 Through m
Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
[TBL] [Abstract][Full Text] [Related]
6. The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory reaction in the premetastatic niche.
Blavier L; Nakata R; Neviani P; Sharma K; Shimada H; Benedicto A; Matei I; Lyden D; DeClerck YA
J Extracell Vesicles; 2023 May; 12(5):e12326. PubMed ID: 37194998
[TBL] [Abstract][Full Text] [Related]
7. Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway.
Koni M; Lopatina T; Grange C; Sarcinella A; Cedrino M; Bruno S; Buffolo F; Femminò S; Camussi G; Brizzi MF
Pharmacol Res; 2023 Sep; 195():106871. PubMed ID: 37506784
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Jung HH; Kim JY; Cho EY; Lee JE; Kim SW; Nam SJ; Park YH; Ahn JS; Im YH
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958571
[TBL] [Abstract][Full Text] [Related]
10. The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs).
Howard J; Goh CY; Gorzel KW; Higgins M; McCann A
Transl Oncol; 2022 Jan; 15(1):101247. PubMed ID: 34678587
[TBL] [Abstract][Full Text] [Related]
11. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription.
Yang W; Li J; Zhang M; Yu H; Zhuang Y; Zhao L; Ren L; Gong J; Bi H; Zeng L; Xue Y; Yang J; Zhao Y; Wang S; Gao S; Fu Z; Li D; Zhang J; Wang T; Shan M; Tang B; Li X
J Exp Clin Cancer Res; 2022 Feb; 41(1):67. PubMed ID: 35180863
[TBL] [Abstract][Full Text] [Related]
13. Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming.
Lopatina T; Grange C; Cavallari C; Navarro-Tableros V; Lombardo G; Rosso A; Cedrino M; Pomatto MAC; Koni M; Veneziano F; Castellano I; Camussi G; Brizzi MF
Oncogenesis; 2020 Oct; 9(10):90. PubMed ID: 33040091
[TBL] [Abstract][Full Text] [Related]
14. Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5.
Rabe DC; Walker ND; Rustandy FD; Wallace J; Lee J; Stott SL; Rosner MR
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298673
[TBL] [Abstract][Full Text] [Related]
15. NUPR1 promotes the proliferation and migration of breast cancer cells by activating TFE3 transcription to induce autophagy.
Xiao H; Long J; Chen X; Tan MD
Exp Cell Res; 2022 Sep; 418(1):113234. PubMed ID: 35660538
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer.
Dong M; Liu Q; Xu Y; Zhang Q
Front Cell Dev Biol; 2022; 10():842898. PubMed ID: 35300426
[TBL] [Abstract][Full Text] [Related]
17. Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype.
Kobayashi S; Kondo N; Tomiyama T; Nakamura N; Masuda M; Matsumoto Y; Honzawa Y; Tahara T; Ikeura T; Fukui T; Okazaki K; Naganuma M
Cancer Immunol Immunother; 2023 Nov; 72(11):3651-3664. PubMed ID: 37597014
[TBL] [Abstract][Full Text] [Related]
18. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
19. EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells.
Gonzalez Suarez N; Fernandez-Marrero Y; Hébert MPA; Roy ME; Boudreau LH; Annabi B
Cancer Cell Int; 2023 Oct; 23(1):240. PubMed ID: 37833751
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome.
Tkach M; Thalmensi J; Timperi E; Gueguen P; Névo N; Grisard E; Sirven P; Cocozza F; Gouronnec A; Martin-Jaular L; Jouve M; Delisle F; Manel N; Rookhuizen DC; Guerin CL; Soumelis V; Romano E; Segura E; Théry C
Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2107394119. PubMed ID: 35439048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
